<DOC>
	<DOCNO>NCT02109822</DOCNO>
	<brief_summary>The goal research study well understand current treatment practice pulmonary exacerbation ( lung infection ) whether Cystic Fibrosis National Patient Registry ( CFFNPR ) use type study .</brief_summary>
	<brief_title>Pilot Observational Study Determine Feasibility Standardized Treatment Pulmonary Exacerb . Patients With CF</brief_title>
	<detailed_description>Cystic fibrosis ( CF ) , life-shortening genetic disease , mark acute episode symptom lung infection increase lung function decrease . These pulmonary exacerbation ( PEs ) treat vary antibiotic vary time period base need determine individual patient , family , health care provider . Cystic fibrosis pulmonary guideline treatment PE publish Cystic Fibrosis Foundation ( CFF ) 2009 provide recommendation treatment also identify key question additional study need . Standard treatment PE involve many facet include selection antibiotic , duration use , outcomes define treatment success . Understanding current treatment practice measure treatment success need study design define optimal treatment strategy . This multi-center , prospective , observational study design prospectively follow patient CF initially admit hospital treatment pulmonary exacerbation .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<mesh_term>Pulmonary Fibrosis</mesh_term>
	<criteria>Male female â‰¥12 year age Visit 1 Enrolled CFFNPR ( Patients may enroll Registry Visit 1 previously enrol . ) Current hospitalization treatment pulmonary exacerbation Planned hospital admission least 5 day intravenous ( IV ) antibiotic Visit 1 Able perform spirometry admission willing perform spirometry subsequent treatment visit day Willing able complete symptom score daily Willing return follow visit end treatment ( necessary ) 28 day start IV antibiotic therapy Written inform consent ( assent applicable ) obtain participant participant 's legal representative Previous enrollment study Treatment IV antibiotic 6 week prior Visit 1 Admission intensive care unit current pulmonary exacerbation Pneumothorax admission Current hospitalization schedule pulmonary clean Current hospitalization sinusitis primary diagnosis Massive hemoptysis define &gt; 250 cc 24 hour period , 100 cc/day 4 consecutive day occur within one week Visit 1 Current pulmonary exacerbation think due allergic bronchopulmonary aspergillosis ( ABPA ) Ongoing treatment prednisone equivalent &gt; 10 mg/day great 2 week initiate prior Visit 1 History solid organ transplantation Currently receive antimicrobial therapy treat nontuberculous mycobacterium ( e.g. , M. abscessus , M. avium complex )</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Cystic Fibrosis</keyword>
	<keyword>Pulmonary Exacerbation</keyword>
	<keyword>Lung Infection</keyword>
	<keyword>Cystic Fibrosis Foundation</keyword>
	<keyword>Cystic Fibrosis Foundation National Patient Registry</keyword>
</DOC>